Virtual reality for clinical use has moved from a future promise to a tool in active use in healthcare settings. In Portugal, adoption has grown gradually and pragmatically. This guide summarises where it is already used, what the evidence says, the regulatory framing, and how a Portuguese institution can start.
Where it is already used in Portugal
Adoption happens mostly in settings where immersion helps capture attention, reduce anxiety or stimulate cognition:
- Care homes and residential facilities for older adults. Cognitive stimulation, reminiscence of familiar places, wellbeing and reducing isolation.
- Hospitals and clinics. Distraction and pain management during procedures, pre-operative anxiety, support in oncology and haemodialysis.
- Rehabilitation and physiotherapy. Supporting adherence and engagement in motor programmes.
- Home and long-term care. Relaxation, wellbeing and remote support, including in places without good internet.
In all these cases, virtual reality is a complementary tool, applied under the supervision of healthcare professionals and integrated into a care plan — never a substitute for treatment.
What the evidence says
International research has shown encouraging results for using virtual reality as a non-pharmacological approach, particularly in:
- Pain management through immersive distraction during procedures.
- Anxiety reduction in clinical and pre-operative settings.
- Cognitive stimulation and wellbeing in older adults.
- Rehabilitation support for motor function and adherence.
At the same time, honesty matters: evidence varies by application, and virtual reality works best as a complement to good clinical practice, not in isolation. A serious institution communicates the benefits without exaggerating them.
The useful question is not "does virtual reality work?", but "for what goal, with which patients, and integrated into what care?".
Framing: medical device and GDPR
Two regulatory questions matter in Portugal, both aligned with the European framework:
- Medical device. If the solution has a declared therapeutic purpose, it may be classed as a medical device — often Class I in the EU — with CE marking. In Portugal, the competent authority is INFARMED. Always ask the vendor for the framing in writing.
- GDPR. Health data is sensitive data. You need a clear legal basis and purpose, data minimisation, security, and transparency with patients and families. Solutions where data stays controlled and content runs locally simplify compliance.
Funding and costs
There is no single, universal reimbursement for virtual reality for clinical use; funding depends on the context (institutional, projects, own budget). In practice, what matters most for the decision is:
- The total cost — device, content, licences, training and support — not just the sticker price.
- The return in staff time saved, patient wellbeing and service differentiation.
- Starting with a small pilot to generate real data before any larger investment.
How a Portuguese institution can start
A practical path, from simplest to broadest:
- Define the clinical goal. A concrete problem — pain, anxiety, cognitive stimulation, rehabilitation.
- Choose one service. A setting where the goal is clear and the team is motivated.
- Run a pilot. A few weeks, with success criteria defined up front.
- Confirm the framing. Regulatory (medical device) and data (GDPR).
- Involve the team. The frontline staff who use it decide real adoption.
- Evaluate and decide. Only then scale, based on data and not impressions.
In short
In Portugal, virtual reality for clinical use is in growing, practical adoption — in care homes, hospitals, clinics and home care. Done well, it is a complementary tool, under supervision, with clear regulatory and data framing. The recommended path is always the same: start small, measure, and only then scale.